Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000711332 | SCV000841673 | uncertain significance | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001360701 | SCV001556632 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 1278 of the CNTNAP2 protein (p.Thr1278Ile). This variant is present in population databases (rs760047247, gnomAD 0.005%). This missense change has been observed in individual(s) with autism spectrum disorder (PMID: 18179895). ClinVar contains an entry for this variant (Variation ID: 585729). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects CNTNAP2 function (PMID: 22872700). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |